News

At the European Society of Cardiology (ESC 2016) Congress late last month, Laila Staerk, MD, of Herlev and Gentofte University Hospital in Denmark, presented the findings of a large study on bleeding among patients with atrial fibrillation who were prescribed various stoke prevention medicines.

There is a known connection between atrial fibrillation and stroke risk. Finding the best way to handle this connection can determine the success of care and the quality of life for patients.

Patients diagnosed with atrial fibrillation will often need treatment extending over a long period of time. In many cases ablation can be the best way to manage their symptoms requiring the work of an electrophysiologist.

A study of Scottish patients who had been treated and cured of hepatitis C found that the group had a higher mortality rate compared to the general population.

“As more states pass laws legalizing recreational marijuana, legislators and health care professionals will need to consider strategies to decrease its effect on young children.”

The family dog has been implicated in an epidemiological study tracing the spread of Clostridium difficile (C. difficile).

Siponimod continues to look promising for multiple sclerosis. Researchers report good results on three-year extension of BOLD study.

Announced at the European Respiratory Society’s International Congress in London, a new meta-analysis published in the Cochrane Library seems to show that vitamin D, in conjunction with standard asthma care, may reduce incidence of asthma attacks.

Researchers say they have found a new and potentially cheaper and better way to diagnose HCV.

We present a round-up of recent news, trial results, and other developments for infectious disease experts and other physicians who treat patients with C. difficile infection.

Criminal cyber attacks on healthcare institutions are on the rise. How can hospitals prevent them? Experts offer strategies.

The treatment of various eye conditions can vary widely depending on where a patient lives. While some countries may have the best technology readily available others are lacking in not only equipment but training.

Lymphopenia may identify an immunologically distinct subset of MS, researchers report.

The European Society of Cardiology's ESC Congress 2016 in Rome, Italy was huge, hot, and full of drama. Will any of the thousands of research reports delivered change practice?

The International Network for Hepatitis C in Substance Users points to economic and pseudo-scientific barriers that keep drug-using hepatitis sufferers from receiving new, effective treatments, including an assumption that illicit drug use reduced the efficacy of certain medications

There have been big steps taken to help combat the opioid abuse epidemic but there is still much more work to be done. Several leading organizations and pharmaceutical companies to help patients with overdose and prevent abuse in the first place.

For patients who do not need opioids or other strong medications for pain management there are other steps that can be taken to help them better manage their symptoms and issues.

One of the biggest concerns in the opioid epidemic is the medications being abused by patients and those who get the drugs through other methods. While technology is being developed to help in this issue getting these changes into the market has been more difficult so far.

The opioid epidemic is clearly a growing problem in the medical community. However, there are concerns that there is so much concern about prescribing opioids that they are not being given who can benefit most from them.

Are people with atopic dermatitis at a higher or lower risk of developing skin cancer? Researchers found conflicting evidence.

How the 9/11 terrorist attacks encouraged the evolution of The One Health Initiative and what that means for the future of medicine.

Genetic analysis can assess the risk of getting multiple sclerosis (MS), but not how severe the disease would be, according to the results of a recent meta-analysis.

Unlike many other diseases Alzheimer's has a unique impact not only on patients but loved ones who see the changes it can cause more than the people it affects directly.

Once a proper diagnosis is made there are a few options doctors and patients can consider when treating Alzheimer's Disease. This includes not only treatment options but how to manage the disease long term.

There are many factors which can contribute to a patient developing Alzheimer's which goes beyond proteins which may be found in the brain.

As new diagnostic techniques are designed for dementia and Alzheimer's Disease in particular it can help with the development of new medications.

It was not very long ago that the only way to accurately diagnose Alzheimer's disease was after a patient had died. Since that time, a lot has been learned about the disease and other forms of dementia.

In the past 15 years, no new topical AD treatments have been approved. Crisaborole, however, could be an efficient, safe, non-steoidal treatment option, according to the results of two recent phase III studies.

Ixekizumab patients, who all started with an introductory 160-mg dose, were all more likely than placebo patients to achieve the primary endpoint of the study: a 20% reduction in disease burden as measured by American College of Rheumatology criteria (an ACR20 response) by week 24.

Analysis of a large cohort group has found a significant connection between gut microbes and 2 of the largest risk factors for diabetes.